featured
2020 Top Stories in Respiratory Medicine: The DEXA-ARDS Trial
Written by
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- Bellani G, Laffey JG, Pham T, et al. Epidemiology, Patterns of Care, and Mortality for Patients with Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. JAMA. 2016;315(8):788-800.
- Cochi SE, Kempker JA, Annangi S, et al. Mortality Trends of Acute Respiratory Distress Syndrome in the United States from 1999-2013. Ann Am Thorac Soc. 2016;13(10):1742-1751.
- Meduri GU, Siemieniuk RAC, Ness RA, et al. Prolonged Low-Dose Methylprednisolone Treatment is Highly Effective in Reducing Duration of Mechanical Ventilation and Mortality in Patients with ARDS. J of Intens Care. 2018;6:53. 2018 Aug 24;6:53. doi: 10.1186/s40560-018-0321-9.
- Annane D, Pastores SM, Rochwerg B, et al. Guidelines for the Diagnosis and Management of Critical Illness-Related Corticosteroid Insufficiency (CIRCI) in Critically Ill Patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. Crit Care Med. 2017;45(12): 2078-2088.
- Villar J, Ferrnado C, Martinez D, et al. Dexamethasone Treatment for the Acute Respiratory Distress Syndrome: a multicentre, randomized controlled trial. Lancet Resp Med. 2020;8(3):267-276.
- Venkatesh B, Finfer S, Cohen J, et al. Adjunctive Glucocorticoid Therapy in Patients with Septic Shock. N Engl J Med. 2018;378(9):797-808.
- Annane D, Renault A, Brun-Buisson C, et al. Hydrocortisone plus Fludrocortisone for Adults with Septic Shock. N Engl J Med. 2018;378:809-818.